BioNote, Inc. (KRX:377740)
4,770.00
-155.00 (-3.15%)
At close: Mar 28, 2025, 3:30 PM KST
BioNote Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | 55,261 | -20,497 | 307,798 | 676,601 | 528,229 | Upgrade
|
Depreciation & Amortization | 8,186 | 8,206 | 6,451 | 4,106 | 1,887 | Upgrade
|
Loss (Gain) From Sale of Assets | -20.25 | -265.2 | -13,412 | -361,225 | 11.45 | Upgrade
|
Asset Writedown & Restructuring Costs | 4,835 | 8,409 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -9,386 | 5,000 | 5,150 | -15,047 | -544.38 | Upgrade
|
Loss (Gain) on Equity Investments | 4,987 | 83,791 | -77,260 | - | -142,571 | Upgrade
|
Stock-Based Compensation | 99.92 | - | 1,637 | 1,985 | 348.06 | Upgrade
|
Provision & Write-off of Bad Debts | 62.32 | -2,845 | -3,596 | 6,827 | 470.16 | Upgrade
|
Other Operating Activities | -12,749 | -82,440 | -4,089 | 34,137 | 172,526 | Upgrade
|
Change in Accounts Receivable | -2,934 | 855.57 | 73,437 | 220,048 | -305,480 | Upgrade
|
Change in Inventory | 10,632 | -436.63 | -33,543 | -9,826 | -48,141 | Upgrade
|
Change in Accounts Payable | -982.63 | 221.23 | -4,573 | -22,140 | 27,513 | Upgrade
|
Change in Other Net Operating Assets | -74.32 | -4,193 | -8,901 | 1,926 | 5,679 | Upgrade
|
Operating Cash Flow | 57,917 | -4,194 | 249,100 | 537,392 | 239,926 | Upgrade
|
Operating Cash Flow Growth | - | - | -53.65% | 123.98% | 2335.49% | Upgrade
|
Capital Expenditures | -10,462 | -3,963 | -42,266 | -51,425 | -26,698 | Upgrade
|
Sale of Property, Plant & Equipment | 727.18 | 94.36 | 49,399 | 174.43 | 78.08 | Upgrade
|
Cash Acquisitions | - | - | - | -6,266 | - | Upgrade
|
Sale (Purchase) of Intangibles | -19.66 | -579.33 | -217.44 | -118.58 | -23.59 | Upgrade
|
Investment in Securities | -72,415 | -477,108 | -37,446 | -133,747 | -84,749 | Upgrade
|
Other Investing Activities | 0 | 0 | - | - | - | Upgrade
|
Investing Cash Flow | -82,170 | -481,555 | -30,530 | -191,383 | -111,393 | Upgrade
|
Short-Term Debt Issued | - | 150,000 | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 10.5 | 50 | - | - | Upgrade
|
Total Debt Issued | - | 150,011 | 50 | - | - | Upgrade
|
Short-Term Debt Repaid | - | -150,000 | - | - | -12,000 | Upgrade
|
Long-Term Debt Repaid | -1,144 | -836 | -415.58 | -216.76 | -79.83 | Upgrade
|
Total Debt Repaid | -1,144 | -150,836 | -415.58 | -216.76 | -12,080 | Upgrade
|
Net Debt Issued (Repaid) | -1,144 | -825.5 | -365.58 | -216.76 | -12,080 | Upgrade
|
Issuance of Common Stock | - | 843.66 | 73,280 | - | - | Upgrade
|
Repurchase of Common Stock | -3,108 | - | - | - | - | Upgrade
|
Dividends Paid | -20,411 | -49,919 | -49,959 | -49,959 | - | Upgrade
|
Other Financing Activities | - | - | -0 | -420 | 415 | Upgrade
|
Financing Cash Flow | -24,663 | -49,901 | 22,955 | -50,596 | -11,665 | Upgrade
|
Foreign Exchange Rate Adjustments | 8,862 | 1,978 | 20,930 | 118.56 | -364.69 | Upgrade
|
Net Cash Flow | -40,054 | -533,672 | 262,455 | 295,532 | 116,504 | Upgrade
|
Free Cash Flow | 47,454 | -8,156 | 206,834 | 485,966 | 213,228 | Upgrade
|
Free Cash Flow Growth | - | - | -57.44% | 127.91% | 2458.84% | Upgrade
|
Free Cash Flow Margin | 46.17% | -9.05% | 43.12% | 78.09% | 33.77% | Upgrade
|
Free Cash Flow Per Share | 465.43 | -79.98 | 2193.65 | 5186.94 | 2279.15 | Upgrade
|
Cash Interest Paid | 233.55 | 602.82 | 84.44 | 44.25 | 165.72 | Upgrade
|
Cash Income Tax Paid | 5,003 | 40,454 | 157,006 | 171,252 | 993.03 | Upgrade
|
Levered Free Cash Flow | 14,076 | -18,697 | 129,964 | 399,410 | 150,205 | Upgrade
|
Unlevered Free Cash Flow | 14,222 | -18,321 | 130,017 | 399,438 | 150,313 | Upgrade
|
Change in Net Working Capital | -8,822 | -7,495 | 20,219 | -151,924 | 173,970 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.